Number of the records: 1
Therapy for minimal residual tumour disease: beta-galactosylceramide inhibits growth of recurrent HPV16-associated neoplasms after surgery and chemotherapy
- 1.
SYSNO 0333598 Title Therapy for minimal residual tumour disease: beta-galactosylceramide inhibits growth of recurrent HPV16-associated neoplasms after surgery and chemotherapy Author(s) Šímová, Jana (UMG-J) RID
Indrová, Marie (UMG-J) RID
Bieblová, Jana (UMG-J)
Mikyšková, Romana (UMG-J) RID
Bubeník, Jan (UMG-J)
Reiniš, Milan (UMG-J) RIDSource Title International Journal of Cancer. Roč. 126, č. 12 (2010), s. 2997-3004. - : Wiley Document Type Článek v odborném periodiku Grant GA301/06/0774 GA ČR - Czech Science Foundation (CSF) IAA500520807 GA AV ČR - Academy of Sciences of the Czech Republic (AV ČR) GA301/07/1410 GA ČR - Czech Science Foundation (CSF) GA301/09/1024 GA ČR - Czech Science Foundation (CSF) 18933, XE - EU countries CEZ AV0Z50520514 - UMG-J (2005-2011) Language eng Country DE Keywords beta-galactosylceramide * tumour immunotherapy * NKT cells Permanent Link http://hdl.handle.net/11104/0178543 File Download Size Commentary Version Access 0333598.pdf 5 380.1 KB Publisher’s postprint require
Number of the records: 1